TNLX — Trans Lux Share News
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $0.01m
- $5.15m
- $12.86m
Australia's Telix Pharmaceuticals rises on China acceptance of new drug application
Australia's Telix Pharmaceuticals jumps after Jefferies hikes PT
Jefferies raises PT on Australia's Telix Pharmaceuticals on upbeat U.S. sales
Australia's Telix Pharma posts worst day in four months on discounted placement
Telix Pharma hits record high as co edges closer to product launch in Europe
Australia's Telix Pharma rises on FDA nod for kidney cancer midstage study
Australia's Telix Pharma rises as candidate for bone marrow disease meets goals
Focus: Vietnam's answer to Tesla has U.S. in its electric sights
Telix Pharma hits record high, partners with S.Korean firm for cancer imaging product
Brief: Trans Lux Q4 EPS $0.14